📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
5 articles
AVG GRADE
NEUTRAL
score: 0.20
SENTIMENT
NEUTRAL
TOTAL VIEWS
15
VXRT Stock Analysis & AI Grade: NEUTRAL
5 articles analyzed · Sentiment: NEUTRAL · AI-powered equity research
RECENT COVERAGE · 4 ARTICLES
Vaxart to Participate in BTIG Biotechnology Conference 2026
Vaxart (VXRT) announced management participation in the BTIG Virtual Biotechnology Conference scheduled for July 28, 2026. This...
Vaxart Investors Reject Say-on-Pay as CEO Rules Out Reverse Split for Now
Vaxart (VXRT) held its 2026 Annual Meeting, where shareholders re-elected the full board and ratified the auditor, signaling baseline...
Vaxart Announces Results of Annual Meeting of Stockholders
Vaxart held its annual shareholder meeting on July 17, 2026, in a virtual format. The company is a clinical-stage biotech developer...
Vaxart Reports Topline 12-Month Safety Data From the 400-Participant Sentinel Safety Cohort of the Phase 2b Clinical Trial of Its Oral Pill COVID-19 Vaccine
Vaxart disclosed 12-month safety outcomes from a 400-participant cohort of its Phase 2b oral COVID-19 vaccine trial, reporting no...
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice